Wirkstoffe & Arzneimittelsicherheit

Gegenanzeigen · Binocrit

Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6 000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7 000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8 000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9 000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30 000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40 000 IU/1 mL solution for injection in a pre-filled syringe · Abschnitt 4.3 · PDF-Seite 10–11

HOS-208637 · Präparat HOS-154153

10 The use of Binocrit in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.